Industry News
Meditech signs collaboration agreement with US firm Hyalose
Cancer therapy developer Meditech (ASX:MTR) has signed a research and development collaboration agreement with Hyalose, a privately-owned US biotech company. [ + ]
Biotechnology student resource revamped
Biotechnology Online, a national education resource aimed at making high-school students more aware of the ethics and scientific principles of biotechnology has been updated and relaunched. [ + ]
WEHI to share in US$21 million Gates grant for malaria research
Prof Alan Cowman and his team at The Walter and Eliza Hall Institute of Medical Research (WEHI) are part of an international consortium that has won a US$13 million Grand Challenge in Global Health grant to develop a treatment for malaria. [ + ]
Epitan raises AUD$3.5 million in private placement
Melbourne's Epitan (ASX:EPT) has raised AUD$3.5 million by way of a private placement, assisted by Mariner Corporate Finance, to institutional investors in Europe and Australia. [ + ]
Peptech awarded third patent for male dog contraceptive
Peptech Animal Health, a subsidiary of Peptech (ASX:PTD), has been granted an additional United States patent increasing the intellectual property protection of its peptide-based male dog contraceptive implant Suprelorin. [ + ]
In brief: GTG, Resonance Health, Sirtex
Genetic Technologies (ASX:GTG) has settled all of its disputes with the Auckland District Health Board, as the representative of all the New Zealand district health boards plus the New Zealand Blood Service. [ + ]
The Burrill view: Get ready for biotech's next phase
Steven Burrill's 'state of the industry' address is the star turn at the annual BIO conference in the US. Iain Scott was in the audience for this year's words of wisdom. [ + ]
New centre to look at approaches to imaging proteins
A new Centre of Excellence in Coherent X-Ray Science will be developed with an AUD$9 million ARC grant over five years, involving Australian and overseas universities and other organisations. [ + ]
Government medical research fund
The Commonwealth Government, through the National Health and Medical Research Council (NHMRC), has announced this year’s successful recipients of grants of a total more than A$100 million for leading medical research and clinical trials being conducted at universities and research centres.
[ + ]Big names on grant winners list
Some of the biggest names in Australian science are among the big winners of more than AUD$100 million in National Health and Medical Research Council grants, announced on Wednesday. [ + ]
Vet Biotech gets green light for horse stem cell therapy
Australian animal health company, Vet Biotechnology, has been given the green light to perform equine supply stem cell therapies for tendon and ligament injuries in Australia. [ + ]
Scientists must stand up on cloning: Boswell
The National Party's leader in the senate, Senator Ron Boswell, has urged scientists to make submissions to the independent committee appointed to review federal laws restricting stem cell research in Australia. [ + ]
Cryptome, NTRI to team up on brain trauma drugs
Melbourne-based Cryptome Pharmaceuticals (ASX:CRP) and the National Trauma Research Institute (NTRI), at the Alfred Hospital, have signed an agreement that will accelerate Cryptome's drug discovery platform in neuroinflammation. [ + ]
AVT Plasma calls in liquidator after China about-face
AVT Plasma (ASX:AVT) has suspended trading in its shares, following a board decision to wind up the company and appoint a provisional liquidator. [ + ]
Tissue Therapies claims success in diabetic ulcer study
A new lab study has shown that Brisbane-based Tissue Therapies' (ASX:TIS) VitroGro technology could stimulate the growth of human skin cells, offering hope for a new treatment for diabetic ulcers, the company said. [ + ]
